The i-Lumen™ AMD device,  software, and therapy regimen are based upon the Company’s proprietary technology, which is patented in the US, Australia, Canada, and the European Union.  The company’s patented technology delivers pulsed microcurrent stimulation in a carefully timed sequence, directed to the retina to help restore the natural function of the Retinal Pigment Epithelium and Muller cells which support the retina’s Neural cells, the cells responsible for processing light and transmitting it to the brain to create an image.

 

CAUTION Investigational device. Limited by Federal (or United States) law to investigational use.